A Study to Determine the Efficiency For Brain Metastasis NSCLC Patients Treated With Icotinib Alone or Combined With Radiation Therapy

Conditions:   Non Small Cell Lung Cancer;   Brain Metastases Interventions:   Drug: Icotinib;   Radiation: SRS/WBRT/HA-WBRT/SMART Sponsor:   Betta Pharmaceuticals Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials